Comment ROI for drug development (Score 5, Interesting) 390
Given that Ebola is currently confined to Africa, and that a relatively small number of people have caught it (less than 4000)...and these outbreaks seem to only come along once every 20 years, where was the incentive for the drug company to create this drug? Was it good timing that it has something ready to go just now.
Will each dose be prohibitively expensive to administer in Africa, or it remains to be seen if WHO will foot the bill to the tune of 10's of millions $$.